Skip to Content
Søk Menu

Molekylär likhet mellan Epstein Barr-virusantigen 1 och anoctamin 2 associerar med ökad MS-risk

Få tillgång

Om du är läkare, sjuksköterska eller annan vårdpersonal kan du komma åt hela artikeln genom att skapa en profil på BestPractice Nordic.

Related

Ulrik Dalgas

Exercise is Essential for Maximizing Cognitive and Physical Functions for Individuals with MS

/ Ulrik Dalgas
ECTRIMS24MS Play the Video 01:47
Marie Lynning

Low Health Literacy is Associated with Lower Levels of Education, Progressive Disease Types and Higher Disease Severity in MS

/ Marie Lynning
ECTRIMS24MS Play the Video 05:20

ECTRIMS 2024: New Data Has the Potential to Paving the Way for More Personalised and Effective Treatment Plans

/ Jan Andreasen
ECTRIMS24MS
Melinda Magyari

Patients with Secondary Progressive MS Have a Higher Mortality than Those with Primary Progressive MS

/ Melinda Magyari
ECTRIMS24MS Play the Video 03:41

Earlier Access to Effective Treatments for Children with MS Reduces the Burden of Long-Term Disability

/ Jan Andreasen
ECTRIMS24MS

ECTRIMS 2024: The World’s Largest MS Congress in Copenhagen 

/ BestPractice Nordic
ECTRIMS24MS
Melinda Magyari

Vaccinations Do Not Increase the Risk of Relapses in Multiple Sclerosis

/ Melinda Magyari
EAN24MS Play the Video 2:46

COVID-19 Vaccination and MS Relapses: Danish National Registry Insights

/ Dominika Stastna
COVID-19MS

Rethinking Neurodegenerative Diseases – The Neurometabolic Concept

/ John Dirk Vestergaard Nieland
ALSAlzheimersMSParkinson
Back to top